30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Prior Stephen David

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Prior Stephen David's trades of AN2 Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-06
S Sale
36,315 +47.5%
470.54
US$2,086,550 		36,315 +47.5% 470.54 US$2,086,550
2026-01-07 2026-01-05
S Sale
89,584 -7.9%
366.06
US$2,982,141 		89,584 -7.9% 366.06 US$2,982,141
2025-11-06 2025-11-04
PlS Planned sale
52,469 -9.5%
104.84
US$3,335,662 		52,469 -9.5% 104.84 US$3,335,662
2025-01-07 2025-01-03
S Sale
2,029 -5.7%
1.34
US$2,721 		2,029 -5.7% 1.34 US$2,721